Mechanisms of Immunosuppression in Colorectal Cancer

CRC is the third most diagnosed cancer in the US with the second-highest mortality rate. A multi-modality approach with surgery/chemotherapy is used in patients with early stages of colon cancer. Radiation therapy is added to the armamentarium in patients with locally advanced rectal cancer. While s...

Full description

Bibliographic Details
Main Authors: Yang Zhang, Ashwani Rajput, Ning Jin, Jing Wang
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/12/12/3850
id doaj-2422c74580fe409ca6c793198c3b53b0
record_format Article
spelling doaj-2422c74580fe409ca6c793198c3b53b02020-12-21T00:01:13ZengMDPI AGCancers2072-66942020-12-01123850385010.3390/cancers12123850Mechanisms of Immunosuppression in Colorectal CancerYang Zhang0Ashwani Rajput1Ning Jin2Jing Wang3Department of Cancer Biology and Abramson Family Cancer Research Institute, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USAJohns Hopkins Sidney Kimmel Cancer Center, National Capital Region, Sibley Memorial Hospital, 5255 Loughboro Road NW, Washington, DC 20016, USADivision of Medical Oncology, Department of Internal Medicine, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USADepartment of Cancer Biology and Genetics, James Comprehensive Cancer Center, The Ohio State University Wexner Medical Center, Columbus, OH 43210, USACRC is the third most diagnosed cancer in the US with the second-highest mortality rate. A multi-modality approach with surgery/chemotherapy is used in patients with early stages of colon cancer. Radiation therapy is added to the armamentarium in patients with locally advanced rectal cancer. While some patients with metastatic CRC are cured, the majority remain incurable and receive palliative chemotherapy as the standard of care. Recently, immune checkpoint blockade has emerged as a promising treatment for many solid tumors, including CRC with microsatellite instability. However, it has not been effective for microsatellite stable CRC. Here, main mechanisms of immunosuppression in CRC will be discussed, aiming to provide some insights for restoring immunosurveillance to improve treatment efficacy in CRC.https://www.mdpi.com/2072-6694/12/12/3850colorectal cancerimmunosuppressionimmunotherapymicrosatellite stablecell surface proteincytokine
collection DOAJ
language English
format Article
sources DOAJ
author Yang Zhang
Ashwani Rajput
Ning Jin
Jing Wang
spellingShingle Yang Zhang
Ashwani Rajput
Ning Jin
Jing Wang
Mechanisms of Immunosuppression in Colorectal Cancer
Cancers
colorectal cancer
immunosuppression
immunotherapy
microsatellite stable
cell surface protein
cytokine
author_facet Yang Zhang
Ashwani Rajput
Ning Jin
Jing Wang
author_sort Yang Zhang
title Mechanisms of Immunosuppression in Colorectal Cancer
title_short Mechanisms of Immunosuppression in Colorectal Cancer
title_full Mechanisms of Immunosuppression in Colorectal Cancer
title_fullStr Mechanisms of Immunosuppression in Colorectal Cancer
title_full_unstemmed Mechanisms of Immunosuppression in Colorectal Cancer
title_sort mechanisms of immunosuppression in colorectal cancer
publisher MDPI AG
series Cancers
issn 2072-6694
publishDate 2020-12-01
description CRC is the third most diagnosed cancer in the US with the second-highest mortality rate. A multi-modality approach with surgery/chemotherapy is used in patients with early stages of colon cancer. Radiation therapy is added to the armamentarium in patients with locally advanced rectal cancer. While some patients with metastatic CRC are cured, the majority remain incurable and receive palliative chemotherapy as the standard of care. Recently, immune checkpoint blockade has emerged as a promising treatment for many solid tumors, including CRC with microsatellite instability. However, it has not been effective for microsatellite stable CRC. Here, main mechanisms of immunosuppression in CRC will be discussed, aiming to provide some insights for restoring immunosurveillance to improve treatment efficacy in CRC.
topic colorectal cancer
immunosuppression
immunotherapy
microsatellite stable
cell surface protein
cytokine
url https://www.mdpi.com/2072-6694/12/12/3850
work_keys_str_mv AT yangzhang mechanismsofimmunosuppressionincolorectalcancer
AT ashwanirajput mechanismsofimmunosuppressionincolorectalcancer
AT ningjin mechanismsofimmunosuppressionincolorectalcancer
AT jingwang mechanismsofimmunosuppressionincolorectalcancer
_version_ 1724375999253053440